Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
10.10.23
/
50%
€34.40
Target price
10.10.24
€84.74
Performance (%)
43.02%
End price
11.10.24
€49.20
Summary
This prediction ended on 11.10.24 with a price of €49.20. With a performance of 43.02% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% | -52.074% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Morgan Stanley from $95.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€31.20
09.05.25
09.05.25
€57.96
09.05.26
09.05.26
-35.26%
05.02.26
05.02.26
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€24.00
14.07.25
14.07.25
€47.06
14.07.26
14.07.26
-15.83%
05.02.26
05.02.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
30.05%
04.11.24
04.11.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.60
04.08.23
04.08.23
€86.28
04.08.24
04.08.24
30.06%
05.08.24
05.08.24